These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2417705)

  • 21. Leucocyte versus erythrocyte thioguanine nucleotide concentrations in children taking thiopurines for acute lymphoblastic leukaemia.
    Lancaster DL; Patel N; Lennard L; Lilleyman JS
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):33-6. PubMed ID: 12111109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The regulation of hypoxanthine guanine phosphoribosyl transferase activity through transfer of PRPP by metabolic cooperation.
    Vitkauskas G; Canellakis ES
    Exp Cell Res; 1984 Jun; 152(2):541-51. PubMed ID: 6202536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N
    Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substitution of lysine for arginine at position 199 of a hypoxanthine phosphoribosyltransferase interferes with binding of the primary substrate to the active site.
    Craig SP; Focia PJ; Fletterick RJ
    Biochim Biophys Acta; 1997 Apr; 1339(1):1-3. PubMed ID: 9165092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Factors altering purine metabolism in liver cells].
    Lalanne M; Des Rosiers C; Willemot J
    Rev Can Biol Exp; 1982 Mar; 41(1):65-71. PubMed ID: 6179131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical approaches to enhancement of antitumor drug selectivity: selective protection of cells from 6-thioguanine and 6-mercaptopurine by adenosine.
    Jackson RC; Ross DA; Harkrader RJ; Epstein J
    Cancer Treat Rep; 1980; 64(12):1347-53. PubMed ID: 6162556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A sensitive multilayer immunoalkaline phosphatase method for detection of P-glycoprotein in leukemic and tumor cells in the bone marrow.
    Haddad G; Thorner PS; Bradley G; Dalton WS; Ling V; Chan HS
    Lab Invest; 1994 Oct; 71(4):595-603. PubMed ID: 7967514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The route of non-enzymic and enzymic breakdown of 5-phosphoribosyl 1-pyrophosphate to ribose 1-phosphate.
    Trembacz H; Jezewska MM
    Biochem J; 1990 Nov; 271(3):621-5. PubMed ID: 1700897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lesch-Nyhan syndrome: biochemical characterization of a case with attenuated behavioral manifestation.
    Fattal A; Spirer Z; Zoref-Shani E; Sperling O
    Enzyme; 1984; 31(1):55-60. PubMed ID: 6201351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxanthine-guanine phosphoribosyl transferase with altered substrate affinity in mutant mouse lymphoma cells.
    Friedrich U; Coffino P
    Biochim Biophys Acta; 1977 Jul; 483(1):70-8. PubMed ID: 560213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered 5-phosphoribosyl 1-pyrophosphate amidotransferase activity in 6-thioguanine-resistant HL-60 human acute promyelocytic leukemia cells.
    Ishiguro K; Sartorelli AC
    Cancer Res; 1984 Sep; 44(9):3679-85. PubMed ID: 6589043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of intracellular folate concentration on the modulation of 5-fluorouracil cytotoxicity by the elevation of phosphoribosylpyrophosphate in cultured human KB cells.
    Kane MA; Roth E; Raptis G; Schreiber C; Waxman S
    Cancer Res; 1987 Dec; 47(24 Pt 1):6444-50. PubMed ID: 2445472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia.
    Dokmanovic L; Urosevic J; Janic D; Jovanovic N; Petrucev B; Tosic N; Pavlovic S
    Ther Drug Monit; 2006 Dec; 28(6):800-6. PubMed ID: 17164697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired transport as a mechanism of resistance to thiopurines in human T-lymphoblastic leukemia cells.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1039-44. PubMed ID: 17065061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrophilic-interaction liquid chromatography-tandem mass spectrometric determination of erythrocyte 5-phosphoribosyl 1-pyrophosphate in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Hasegawa H; Shinohara Y; Nozaki S; Nakamura M; Oh K; Namiki O; Suzuki K; Nakahara A; Miyazawa M; Ishikawa K; Himeno T; Yoshida S; Ueda T; Yamada Y; Ichida K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 976-977():55-60. PubMed ID: 25482009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Purine metabolism: determination of PRPP-amidotransferase and PRPP-synthetase in lymphocytes from patients with chronic lymphatic leukemia (CLL)].
    Tabucchi A; Terzuoli L; Di Stefano A; Pizzichini M; Leoncini R; Dispensa E; Marinello E
    Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1097-103. PubMed ID: 2560926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.
    Becker MA; Losman MJ; Itkin P; Simkin PA
    J Lab Clin Med; 1982 Apr; 99(4):495-511. PubMed ID: 6174658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental modulation of PRPP availability for ribonucleotide synthesis from hypoxanthine in human skin fibroblast cultures.
    Holland MJ; Klein NC; Cox RP
    Exp Cell Res; 1978 Feb; 111(2):237-43. PubMed ID: 627232
    [No Abstract]   [Full Text] [Related]  

  • 40. How low is too low? Use of cluster analysis to define low levels of mercaptopurine metabolites.
    Traore F; O'Riordan MA; Myers C; Groth K; Hoff A; Angiolillo A; Rheingold S; Drotar D; Kodish E
    Pediatr Blood Cancer; 2006 Feb; 46(2):187-92. PubMed ID: 16086421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.